EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASEExecutive Termination Agreement and General Release • November 10th, 2008 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledNovember 10th, 2008 Company Industry JurisdictionThis EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASE (“Executive Termination Agreement” or “Agreement”) is entered into between Alan Fuhrman (“Executive”) and Sonus Pharmaceuticals, Inc. (to be renamed “OncoGenex Pharmaceuticals, Inc.”) (referred to herein as “Sonus” or “Employer”).
EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASEExecutive Termination Agreement and General Release • November 10th, 2008 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledNovember 10th, 2008 Company Industry JurisdictionThis EXECUTIVE TERMINATION AGREEMENT AND GENERAL RELEASE (“Executive Termination Agreement” or “Agreement”) is entered into between Michael A. Martino (“Executive”) and Sonus Pharmaceuticals, Inc. (to be renamed “OncoGenex Pharmaceuticals, Inc.”) (“Sonus” or “Employer”).